MYBL1 and cancer: Importantly, we found that both the pan-HDAC inhibitor Saha and the HDAC4 specific inhibitor Lmk-235 significantly decreased the mRNA level of the transcription factor MybL1 in MIA PaCa-2 and PANC-1 cancer cells (Fig. 4E).